Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

BMJ debates patient group sponsorship

The current issue of the British Medical Journal debates the sponsorship of patient groups by drug companies in a "Head to Head".

Alastair Kent argues in favour of accepting money from the drug companies stating that not accepting sponsorship will limit the effectiveness of patient groups.

Barbara Mintzes argues against accepting money from the drug companies stating that, in accepting the money, the independence of the patient group is undermined.

The issue of sponsorship will always be a topic for debate. In the meantime, all patient groups should declare full details of sponsorship and provide easy access to this information. This transparent approach would improve confidence in the independence of the patient group and also allow individuals to assess any potential for bias.

Action: Clinicians should consider the transparency and bias of patient groups before implementing any recommendations made by these groups.

Share 'BMJ debates patient group sponsorship' on Email Share 'BMJ debates patient group sponsorship' on Delicious Share 'BMJ debates patient group sponsorship' on Digg Share 'BMJ debates patient group sponsorship' on Facebook Share 'BMJ debates patient group sponsorship' on Google+ Share 'BMJ debates patient group sponsorship' on reddit Share 'BMJ debates patient group sponsorship' on StumbleUpon Share 'BMJ debates patient group sponsorship' on Twitter

atomic-wealth

No Comments to “BMJ debates patient group sponsorship”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,309 spam comments.

atomic-wealth
fond-illness
summer